<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
   <channel>
      <title>Healthcare Packaging</title>
      <link>http://www.healthcarepackaging.com/</link>
      <description>News for healthcare packaging, pharmaceutical and medical device industries. Topics include RFID, packaging materials, labeling, package design, validation, and more in the healthcare packaging field.</description>
      <language>en</language>
      <copyright>Copyright 2012</copyright>
      <lastBuildDate>Tue, 15 May 2012 07:04:35 +0000</lastBuildDate>
      <generator>http://www.sixapart.com/movabletype/?v=4.23-en</generator>
      <docs>http://blogs.law.harvard.edu/tech/rss</docs> 

      
      <item>
         <title>SuperCorrExpo® Opens Registration</title>
         <description><![CDATA[<p>Registration is now open for SuperCorrExpo®, the most powerful global hub of corrugated technology. Industry veterans and newcomers alike can sign up to experience more than 100,000 square feet of working corrugated machinery, the first-ever TAPPI/AICC joint conference program, and keynote presentations from six leading voices in corrugated, converting and business segments. SuperCorrExpo will take place Oct. 1-4, 2012 at the Georgia World Congress Center in Atlanta. Registration is available <a href="http://www.supercorrexpo.org">online</a>.</p>

<p>&#8220;We&#8217;re excited to open registration and let people be a part of this can&#8217;t-miss event,&#8221; said Larry N. Montague, president and CEO of <a href="http://www.tappi.org/">TAPPI</a>. &#8220;With so many corrugated equipment manufacturers, buyers and service providers gathering in one place from throughout the globe, SuperCorrExpo is the most important corrugated show in the world. We are confident that those who attend will find it to be a week that will have a profound impact on their businesses.&#8221;</p>

<p>&#8220;SuperCorrExpo is the very best show in our industry,&#8221; said Steve Young, president of AICC.  &#8220;From the beginning of our partnership, AICC and TAPPI have designed SuperCorrExpo as an industry-wide event to benefit and educate our members on the state-of-the-art in corrugated technology.&#8221;</p>

<p>SuperCorrExpo is offering a discount for box plants so that they can bring an unlimited number of employees from the same plant for one single price. Once there, they&#8217;ll be able to participate in personalized tours with exhibitors, attend technical presentations to learn about advances in the industry, and network with other professionals who can help them transform their operations for increased profitability. Details of the box plant discount are available <a href="http://www.supercorrexpo.org">here</a>.</p>

<p>Exhibitors at SuperCorrExpo include those who provide services, machinery, equipment, materials, supplies, software, tools or tooling to the corrugated paperboard industry. Attendees will be able to see the exhibition, conference and keynote speakers throughout the entire week for one price. </p>

<p>The first 200 people to register for the full TAPPI / AICC conference will receive a copy of the book, &#8220;Running the Gauntlet,&#8221; written by one of the keynote speakers, Jeffrey Hayzlett.<br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/supercorrexpo_opens_registrati.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/supercorrexpo_opens_registrati.php</guid>
         <category>Community News</category>
         <pubDate>Tue, 15 May 2012 07:04:35 +0000</pubDate>
      </item>
      
      <item>
         <title>Bosch Receives German Ideas Award 2012</title>
         <description><![CDATA[<p>The manufacturing location of Robert Bosch GmbH in Homburg/Saar was presented with the German Ideas Award (DeutscheIdeenPreis) in Dresden. The award for ideas management is conferred each year by the German Institute for Business Administration along with representatives from science, politics and industry. The submitted contributions were evaluated based on their added socio-cultural, ecological and economic value as well as the degree of innovation, feasibility and transferability.</p>

<p>The <a href="http://www.bosch.com">Bosch</a> plant in Homburg took part with its structured communications model for energy management in the category &#8220;Environmental Idea - Best Green Innovation&#8221; and in addition received the overall award for the &#8220;Idea of the Year.&#8221; Dr. Uwe Gackstatter, Executive Vice President, Finance and Administration, of the Diesel Systems Division and Thomas Gönner, Technical Director of the Homburg plant, accepted the award for the Bosch workforce in Homburg.</p>

<p>Energy Efficiency Projects at Bosch in Homburg<br />
The Bosch company is particularly committed to environmental protection and resolute energy management. In this context, for example, the Bosch plant in Homburg is a founding member of the Saarland energy efficiency network which was began in 2010. Already in recent years greater focus was placed on energy efficiency topics at the Homburg business location. </p>

<p>This resulted in a reduction of carbon dioxide emissions amounting to several thousand tons. Numerous projects were implemented in order to optimize workshops, machines and plants in terms of their energy consumption. The aim at Bosch is to reduce carbon dioxide emissions by 20 percent by the year 2020 compared with the year 2007.</p>

<p>Raising Staff Consciousness for Energy Management<br />
Within the scope of energy management, Bosch in Homburg recognized the importance of its workforce as important representatives and disseminators of knowledge and information about increasing energy efficiency. A structured communications model was introduced in order to raise staff consciousness with the aim of long-term modification of their behavior. Thus all staff are included in energy management through standardized staff training. A specially developed short film points out instances of energy waste in their own private surroundings and then applies them to the everyday working world. In doing so staff are provided with information on energy efficiency measures at the business location and are challenged to contribute their own ideas for saving energy through the employee suggestion scheme. At the same time, campaigns are carried out in order to illustrate the topic of energy efficiency; for example, relating to the indication of the energy consumption of production machinery.</p>

<p>As a result of the active commitment on the part of its workforce, Bosch in Homburg was able to significantly reduce its energy consumption. Currently more than 2,000 tons in carbon dioxide emissions have been saved simply through modified, environmentally-conscious behavior of the company's workforce. This corresponds to the annual energy consumption of approximately 1,110 single family homes.</p>

<p>Among other things, injectors and high-pressure pumps for diesel engines, in particular for the utility vehicle market, are manufactured at Bosch in Homburg. A workforce of more than 6,000 is employed at the location. </p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/bosch_receives_german_ideas_aw.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/bosch_receives_german_ideas_aw.php</guid>
         <category>Community News</category>
         <pubDate>Tue, 15 May 2012 06:59:32 +0000</pubDate>
      </item>
      
      <item>
         <title>Aptar Pharma&apos;s clinical study confirms a major advance in dry powder inhalers</title>
         <description><![CDATA[<p>World leader in nasal and pulmonary drug delivery devices, <a href="http://www.aptar.com/pharma">Aptar Pharma</a> will unveil the results of the latest patient-focused clinical studies using the Prohaler® Dry Powder Inhaler, at the upcoming RDD® (Respiratory Drug Delivery) scientific conference. RDD® 2012 will be held in Phoenix, Arizona, from May 15 th-17 th  2012.<br />
 <br />
Aptar Pharma in tune with the market, patients and prescribers<br />
 <br />
Before starting development of Prohaler®, Aptar Pharma carried out a series of investigations and acceptance studies with healthcare professionals. The aim of these studies was to determine Dry Powder Inhaler (DPI) user expectations and preferences.<br />
 <br />
The next step was to extend these investigations to understand the patient/device interface during inhalation and verify that all the necessary conditions were met for the correct dose of medication to be administered.<br />
 <br />
This took place during a hospital-based clinical study which was carried out at the Centre Hospitalier Regional Universitaire (CHRU) in Tours, France. The study was led by Professor Patrice Diot, an eminent respiratory physician and formerly President of ISAM (The International Society for Aerosols in Medicine).<br />
 <br />
Results showed that all study participants with either asthma or Chronic Obstructive Pulmonary Disease (COPD) could trigger the device and inhale enough air for the medication to reach the lungs, regardless of how ill they were.<br />
 <br />
Both patients and doctors surveyed confirmed the advantages of Prohaler® in terms of ergonomics and ease of use. These provide this DPI with optimized handling characteristics for consistent and effective dose delivery. It was clearly demonstrated that Prohaler® met expectations, and had the support of both patients and prescribers.<br />
 <br />
Prohaler®, the smart DPI for optimal patient compliance<br />
 <br />
The Prohaler® DPI has been developed with a patient-based design approach which makes it intuitive and simple to use by all asthma and COPD patients.<br />
 <br />
Prohaler® features a novel powder dispersion technology enabling consistent lung deposition even while operating at relatively low patient inhalation flow rates. The results of the research showed that Prohaler® has excellent ergonomics, providing intuitive and constant handling characteristics. It is easy to use, with only 3 simple steps needed: open the device, inhale and close it; inhaling triggers the release of a full dose of medication. And a dose counter reminds the patient how many doses are left in the device.<br />
 <br />
Prohaler® incorporates visual and audible feed-back systems to facilitate ease-of-use and patient compliance.<br />
 <br />
Prohaler® also has a unique patient safety feature to avoid any risk of double-dosing and wasted doses. And the drug product is protected inside individual blisters which are only opened upon inhalation by the patient, providing optimal powder protection.<br />
 <br />
 <br />
A new step forward in delivering asthma and COPD treatment via the pulmonary route<br />
 <br />
Asthma and COPD are very common chronic diseases. They represent a global market estimated at US$ 31 billion in drug sales in 2011 growing 3% (Datamonitor).<br />
 <br />
The majority of respiratory treatments are delivered via the pulmonary route, using either pressurized Metered Dose Inhalers (pMDIs) or more recently DPIs. Because they eliminate the problem of synchronization between actuation and inhalation, DPIs are considered easier to use than pMDIs. In addition, DPIs do not contain propellant and are therefore more environmentally- friendly.<br />
 <br />
Dr. Gerallt Williams will give a presentation on a Prohaler® patient-focused study during RDD® 2012, the major worldwide scientific event for inhalation science. This presentation, entitled &#8220;Powder Inhaler Modifications Resulting From Patient Focused Testing&#8221;, will take place on May 17th, at 2.30 pm.<br />
 <br />
&#8220;At Aptar Pharma, we are extremely pleased to unveil the results of this new hospital-based patient-focused study with Prohaler® . This device is designed to meet the needs of patients with regard to safety and comfort as well as to satisfy medical professionals&#8217; recommendations, pharmaceutical industry expectations and the requirements of regulatory bodies.&#8221; states Dr. Gerallt Williams, Director Scientific Affairs, Aptar Pharma Prescription Division.<br />
 <br />
For more information on Prohaler®, please visit our table top at RDD 2012 or <a href="http://www.aptar.com/pharma/prescription-division">click here</a>.</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/aptar_pharmas_clinical_study_c.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/aptar_pharmas_clinical_study_c.php</guid>
         <category>Community News</category>
         <pubDate>Tue, 15 May 2012 06:57:53 +0000</pubDate>
      </item>
      
      <item>
         <title>Nanoink expands presence in Japan with prestigious new distributor</title>
         <description><![CDATA[<p>The NanoFabrication Systems Division of <a href="http://www.nanoink.net">NanoInk®</a> is pleased to announce that it has reached a non-exclusive agreement with the Research Institute of Biomolecule Metrology Co., Ltd. (RIBM) to serve as a distributor in Japan. RIBM will distribute NanoInk&#8217;s desktop nanofabrication equipment, including the NLP 2000 System and the DPN 5000 System, which has a wide range of applications ranging from nanoarray-based protein analysis to nano-bioengineering and biomaterial research. As a leader in the visualization and measurement of biomolecules, RIBM aims to spearhead technological advancements in the field of nano-biotechnology.</p>

<p>&#8220;RIBM is a leading player in the Japanese nano-biology industry and has already established a strong relationship with NanoInk&#8217;s target customers in Japan. Its sales and technical teams have the in-depth knowledge required to understand the scientific instrument market and it has proven expertise in selling technically-sophisticated equipment into that space. With these strengths, RIBM is the ideal partner for driving sales of NanoInk&#8217;s unique nanofabrication platforms for use in life science and bioengineering applications,&#8221; said Oliver Yeh, General Manager, NanoInk&#8217;s NanoFabrication Systems Division, Asia-Pacific region. &#8220;We look forward to a close and successful long-term partnership with RIBM as we expand our reach in Japan by promoting the unique capabilities and benefits of the NanoInk line of patterning systems.&#8221;</p>

<p>&#8220;We are delighted to be appointed as a distributor for NanoInk&#8217;s products in Japan&#8217;s life science and bioengineering markets,&#8221; said Dr. Takashi Morii, Director of the Biomolecule Metrology Division at RIBM. &#8220;NanoInk's product lines are complementary to our current product portfolio and are attractive to our targeted nano-biotechnology markets. We look forward to working with the NanoInk team.&#8221;</p>

<p>NanoInk&#8217;s NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory in an easy to use and affordable platform. NanoInk&#8217;s NLP 2000 System is a desktop instrument that allows researchers to rapidly design and create custom engineered and functionalized surfaces by using Dip Pen Nanolithography® (DPN®) to transfer minute amounts of materials over a large, environmentally controlled work area. With the ability to create custom patterns of nano-to-microscale features in under an hour, the NLP 2000 System is valuable for protein and biomolecular patterning, microstructure and biosensor functionalization, cell biology and polymer printing applications.</p>

<p>NanoInk Expands Market Presence in Japan with Prestigious New Distributor</p>

<p>The DPN 5000 System is a full-featured, dedicated instrument for versatile nanopatterning of a variety of materials with nanoscale accuracy and precision. With its user-friendly interface, it is possible to easily design complex patterns while also precisely controlling tip movements during the writing process. The DPN 5000 System is the ideal platform for nanofabrication, nanomaterials and biomaterials applications that exhibit nanoscale printing, imaging and registration requirements.</p>

<p>With locations in Tsukuba, Tokyo, and Hiroshima, RIBM specializes in biomolecule metrology, molecular imaging and food & environmental analysis applications. It develops, manufactures, and sells SPM equipment and conducts contract measurement services using SPM. In addition, it manufactures and sells high-speed AFM for biology which can capture movie images of moving molecules. RIBM also markets nano-measurement equipment and inspects food and environmental samples for genetic modifications, allergens, viruses and residual agricultural chemicals.</p>

<p>To obtain more information or to place an order through RIBM for NanoInk&#8217;s desktop nanofabrication systems, please email <a href="mailto:morii@ribm.co.jp">Dr. Takashi Morii</a>. More background on RIBM is available <a href="http://www.ribm.co.jp/index-e.htm">here</a>.</p>

<p>For information on additional NanoInk distributors, visit <a href="http://nanoink.net/distributors.html">here</a>. More detail about the NanoFabrication Systems Division of NanoInk is available <a href="http://www.nanoink.net/divisions.html#NanoFabrication">here</a>.</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/nanoink_expands_presence_in_ja.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/nanoink_expands_presence_in_ja.php</guid>
         <category>Community News</category>
         <pubDate>Tue, 15 May 2012 06:51:40 +0000</pubDate>
      </item>
      
      <item>
         <title>MWV Presents on Bioequivalence Standards for Drug Delivery Components at Pharmapack NA</title>
         <description><![CDATA[<p>As the generics industry continues to grow - approaching $100 billion in the U.S. - so too does the need for bioequivalence studies that prove generic versions are identical to original formulations. What some might not know is that the rigorous standards and criteria for performing bioequivalence studies also extend to drug delivery components.</p>

<p><a href="http://www.canontradeshows.com/expo/pharma_na12/conf_speakers.html#RabihKaram">Rabih Karam</a>, North American Sales Manager, Healthcare, for <a href="http://www.meadwestvaco.com/index.htm">MeadWestvaco Corporation</a>, a global leader in packaging and packaging solutions,  will present MWV nasal devices equivalence data in his talk &#8220;Equivalence in Nasal Pump Systems for Generic Products in the US Market&#8221; at the inaugural Pharmapack NA pharmaceutical packaging conference in Philadelphia, Wednesday, May 23 at 11:20am. </p>

<p>Please let us know if you would be interested in talking with Rabih, who will also discuss how rigorous bioequivalence studies are an essential part of registration dossiers for the formulation and manufacture of generic medicines. </p>

<p>More information is available <a href="http://www.businesswire.com/news/home/20120515005145/en/MWV-Healthcare-Present-Inaugural-Pharmapack-North-America">here</a>.<br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/mwv_presents_on_bioequivalence.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/mwv_presents_on_bioequivalence.php</guid>
         <category>Community News</category>
         <pubDate>Tue, 15 May 2012 06:47:36 +0000</pubDate>
      </item>
      
      <item>
         <title>PLZ Aeroscience Acquires Assured Packaging</title>
         <description><![CDATA[<p><a href="http://www.plzaeroscience.com">PLZ Aeroscience</a> is pleased to announce the acquisition of Assured Packaging, located in Mississauga, Ontario, Canada.  Assured is Canada's leading custom manufacturer of aerosols for the health and beauty aids, pharmaceutical, food and household market categories.  With the Assured Packaging acquisition and the purchase of K-G Spray-Pak in 2011, PLZ Aeroscience is now the largest and most diversified custom aerosol filler in Canada. "This is a particularly strategic acquisition by PLZ Aeroscience, as it provides the opportunity to apply the same excellent standards of research, and high quality and responsive service to the Personal Care and OTC markets as they have done in the specialty aerosol market,"  stated Rob Theroux, PLZ Aeroscience Canadian Division Manager.</p>

<p>The acquisition was made possible by the continued support of Olympus Partners, a Stamford, Connecticut-based private equity firm focused on providing equity capital for middle market management buyouts and for companies needing capital for expansion. Olympus, which manages over $3 billion in capital, is an active, long-term investor across a broad range of industries, including healthcare services, financial services, consumer products and business services. Manu Bettegowda of Olympus Partners commented, "We are excited about this PLZ Aeroscience acquisition as it continues to leverage PLZ Aeroscience as a platform for growth in the custom aerosol packaging sector, now with a solid footing in the household and personal care market."</p>

<p>PLZ Aeroscience is the leading manufacturer and marketer of specialty aerosol products in North America.  Its subsidiaries formulate, blend, fill and package more than 2,500 brand and private label products, including industrial solvents, lubricants and degreasers, adhesives, sanitary supply disinfectants, insecticides, cleaners, polishes, air fresheners, and personal care items. Headquartered in St. Clair, Missouri, PLZ Aeroscience has built a reputation for research and development expertise, superior customer inventory management and unmatched engineering excellence that allow PLZ Aeroscience to compete in both the short- and high-run segments. </p>

<p>For more information about PLZ Aeroscience and its subsidiaries, visit <a href="http://www.plzaeroscience.com">here</a>.<br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/plz_aeroscience_acquires_assur.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/plz_aeroscience_acquires_assur.php</guid>
         <category>Community News</category>
         <pubDate>Tue, 15 May 2012 06:40:54 +0000</pubDate>
      </item>
      
      <item>
         <title>A medical product packaging primer</title>
         <description><![CDATA[<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><a href="http://www.healthcarepackaging.com/archives/assets_c/2012/05/Fabrico_IntelliDent_Packaging-6118.php" onclick="window.open('http://www.healthcarepackaging.com/archives/assets_c/2012/05/Fabrico_IntelliDent_Packaging-6118.php','popup','width=614,height=283,scrollbars=no,resizable=no,toolbar=no,directories=no,location=no,menubar=no,status=no,left=0,top=0'); return false"><img src="http://www.healthcarepackaging.com/archives/assets_c/2012/05/Fabrico_IntelliDent_Packaging-thumb-225x103-6118.jpg" width="225" height="103" alt="Fabrico_IntelliDent_Packaging.jpg" class="mt-image-none" style="" /></a></span></p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/a_medical_product_packaging_pr.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/a_medical_product_packaging_pr.php</guid>
         <category>Medical devices</category>
         <pubDate>Tue, 15 May 2012 06:31:48 +0000</pubDate>
      </item>
      
      <item>
         <title>Berlin Packaging Acquires Lerman Container</title>
         <description><![CDATA[<p><a href="http://www.berlinpackaging.com/">Berlin Packaging</a>, a leading full-service supplier of plastic, glass, and metal containers and closures, today announced the acquisition of Connecticut-based Lerman Container in a transaction that expands the company's geographic coverage and team of packaging solution experts. The combined company will have 2012 revenues exceeding $700 million, over 110 packaging consultants, and more than 80 sales offices and warehouse locations across North America.  </p>

<p>Established in 1979, Lerman is a packaging distributor with marquee customers across multiple vertical markets. The acquisition:</p>

<p>•	Augments Berlin Packaging's presence in the Northeast by adding Lerman sales and customer service staff in Connecticut and New Jersey, providing easier access to innovative, cost-effective packaging solutions for Berlin Packaging customers in those markets.<br />
•	Adds personal care and pharmaceutical packaging expertise due to Lerman's many years operating in these sectors, complementing Berlin Packaging's own know-how in these areas as well as in other areas including food and beverage, chemical and industrial, household care, lab supply and dangerous goods packaging.<br />
•	Expands the services and specialty offerings available to Lerman's customers through Berlin Packaging's Studio One Eleven design, Berlin Global worldwide sourcing, E3 consulting, Berlin Financial Services lending, Freund Container ordering convenience, Qorpak lab supplies, and Dangerous Goods shipping systems.<br />
•	Enables Berlin Packaging's suppliers to reach new customers in order to grow sales, increase the success of new product introductions, and maximize the amount of product they can remove from their own floor through the warehouse and inventory management programs that Berlin Packaging offers.</p>

<p>The transaction closed on May 14, 2012. It marks Berlin Packaging's third strategic acquisition since 2010, when the company acquired Pittsburgh-based All-Pak and Chicago-based Continental Packaging Solutions. </p>

<p>"The closer we can get to customers geographically, the faster we can serve them and the more attention we can give them. This acquisition makes that possible by adding local presence in important markets as well as top packaging talent and deep vertical industry expertise," said Andrew T. Berlin, Chairman and CEO of Berlin Packaging. "As always, our goal is to help customers increase their net income by optimizing their packaging costs, operations efficiency, and shelf impact. Bringing the Lerman team into our organization strengthens our ability to do that."</p>

<p>"One of the challenges in scaling a business like ours is in maintaining a high level of customer service. Berlin Packaging has been able to do that on a nationwide scale because they share our commitment to helping customers build their bottom line," said Barry Lerman, CEO of Lerman Container. "We will now be doing business as Berlin Packaging, but our customers will receive the same attention, gain access to more products and services, and have a much broader and deeper network of expertise to meet both their custom- and stock-packaging needs."</p>

<p>Berlin Packaging is majority owned by Investcorp, an alternative investment management firm.</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/berlin_packaging_acquires_lerm.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/berlin_packaging_acquires_lerm.php</guid>
         <category>Community News</category>
         <pubDate>Mon, 14 May 2012 14:00:47 +0000</pubDate>
      </item>
      
      <item>
         <title>Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Contain More Than the Intended Fill Volume</title>
         <description><![CDATA[<p><strong>AUDIENCE: </strong>Risk Manager, Consumer</p>

<p><strong>ISSUE:</strong> Hospira, Inc. notified healthcare professionals of a recall of one lot of Hydromorphone Hydrochloride Injection 1 MG/ML, due to reports of a single Carpuject containing more than the 1 mL labeled fill volume. Opioid pain medications such as Hydromorphone have life-threatening consequences if overdosed, including respiratory depression (slowed breathing or suspension of breathing), low blood pressure, and reduced heart rate including circulatory collapse.</p>

<p>The affected lot number is 07547LL, with an expiration date of July 1, 2013. The affected lot was distributed in September - October 2011. It was initially distributed to wholesalers and a limited number of hospitals in Alaska, Alabama, Arizona, California, Colorado, Connecticut, District of Columbia, Delaware, Florida, Indiana, Louisiana, Maryland, Massachusetts, Minnesota, Missouri, Mississippi, North Carolina, New Hampshire, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Washington, and Wisconsin.</p>

<p>BACKGROUND: The affected product is a prefilled glass cartridge for use with the Carpuject Syringe system.</p>

<p>RECOMMENDATION: Anyone with an existing inventory should stop use and distribution, quarantine the product immediately, and call Stericycle at 1-888-912-7093 to arrange for the return of the product. Replacement product from other lots is available. Customers can send their DEA 222 form to Hospira, 1635 Stone Ridge Drive, Stone Mountain, GA 30083 to order replacement product.</p>

<p>Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.<br />
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:</p>

<p>Complete and submit the report Online <a href="http://www.fda.gov/medwatch/report.htm">here</a>. <br />
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178<br />
Read the MeDWatch safety alert, including a link to the updated Drug Safety Communication, <a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm304044.htm">here</a>.<br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/hydromorphone_hydrochloride_in.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/hydromorphone_hydrochloride_in.php</guid>
         <category>FDA,  regulatory and legal</category>
         <pubDate>Mon, 14 May 2012 13:59:12 +0000</pubDate>
      </item>
      
      <item>
         <title>Health Robotics&#8217; Global Network Expands into the Gulf Cooperation Council Area (GCC) with PharmaTech</title>
         <description><![CDATA[<p><a href="http://www.health-robotics.com">Health Robotics</a> today announced a new marketing and service channel for its world-leading i.v.STATION ONCO, i.v.SOFT, and i.v.STATION products with United Arab Emirates-based PharmaTech. Health Robotics continues to spearhead the global healthcare industry and persisting on its worldwide quest to provide safe and cost-effective Intravenous Admixture Compounding Automation to hospitals all over the world.</p>

<p>Said Abu Laila, PharmaTech Medical&#8217;s General Manager, stated: &#8220;Health Robotics is the only company in the world that provides hospitals with both Robotics and Non-Robotics&#8217; based Intravenous Admixture Compounding Automation solutions for Chemotherapy, TPNs, and other IVs. As the undisputed global leader in the market with 10 times more installations that all of its worldwide competitors[1] combined, we are extremely fortunate to be able to bring Health Robotics&#8217; world-leading life-critical medical devices to the GCC.&#8221;</p>

<p>Gaspar DeViedma, Health Robotics&#8217; Executive Vice President, stated: &#8220;i.v.STATION ONCO represents Health Robotics&#8217; 2nd Generation Cancer Therapy Compounding robot for syringes and I.V. Bags, several years ahead of its competition1. Amongst the technology innovations pioneered by i.v.STATION ONCO are its: ability to handle pre-attached lines to IV Bags; small footprint [at 15% to 25% of the size/weight of other I.V. Robots]; faster throughput [up to 40 doses per hour instead of 20 doses per hour]; automated tamper-evident syringe capping; and finally, RFID support. Together with i.v.STATION and i.v.SOFT and their extreme price/value advantages over the competition1, we expect to replicate in GCC on long term basis, starting in 2013, our market success.&#8221;<br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/health_robotics_global_network.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/health_robotics_global_network.php</guid>
         <category>Community News</category>
         <pubDate>Mon, 14 May 2012 13:43:57 +0000</pubDate>
      </item>
      
      <item>
         <title>Burgopak Child Resistant Slider Pack now a Multi Award-winning Design</title>
         <description><![CDATA[<p>The <a href="http://burgopakhealthcare.com/">Burgopak</a> Child Resistant (CR) Slider pack is now a multi-award winning design. Since winning the &#8216;Most Innovative Child Resistant Packaging Design&#8217; at Pharmapack Paris 2012 the pack has been awarded the HCPC USA award for &#8216;Innovative Design&#8217;.</p>

<p>The HCPC USA judges agreed on the innovative, novel design of the Burgopak CR pack. They rated the design on its ability to increase pharmaceutical compliance, level of innovative design, unique packaging features and user friendliness. One judge commented that he is "anxious see what impact this unique configuration can have on patient adherence.&#8221;</p>

<p>The Burgopak CR Slider pack incorporates the engaging operating system of the original Burgopak design, while also including senior friendly features. To open the Burgopak CR Slider pack the patient has to push two buttons, one on either side of the pack while simultaneously pulling the end tab. The pack opens to reveal the blister, held in a plastic tray on one side and the patient information in an easy to read booklet format on the other. Once the patient has accessed the medication they simply push the end tab back into the pack and it reengages the CR lock. As the pack itself is CR, there is no additional requirement for tougher CR blister foils, making the pack easier to use for both seniors and those with reduced dexterity. Calendar blister formats can also be used to further assist adherence.</p>

<p>The Burgopak CR Slider pack successfully achieved the U.S. Consumer Product and Safety Commission&#8217;s F=1 for child resistance and senior friendly effectiveness. The pack encourages compliance by keeping the blister, patient information and outer carton connected at all times, it also keeps the pack compact and portable.</p>

<p>Commenting on the double award wins, Tim Clarke, CEO of Burgopak, said: &#8220;Innovation is key to our success. Just winning one award is a great accolade, but for the design to be recognised by two independent judging panels is a great accomplishment for the company&#8221;.</p>

<p>Burgopak Healthcare & Technology will be exhibiting at the inaugural Pharmapack North America exhibition in Philadelphia on the 22nd-23rd May 2012, booth number 922. For any pharmaceutical and healthcare companies interested in meeting at the show, or just to receive a sample of the packaging design, please get in contact with <a href="mailto:tim.bollans@burgopak.com">Tim Bollans</a> at Burgopak on +44 (0) 207 089 1985.</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/burgopak_child_resistant_slide.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/burgopak_child_resistant_slide.php</guid>
         <category>Community News</category>
         <pubDate>Mon, 14 May 2012 13:41:54 +0000</pubDate>
      </item>
      
      <item>
         <title>Cardpak® announces promotion of Seth Duckworth to Vice President sales &amp; marketing</title>
         <description><![CDATA[<p><a href="http://www.cardpak.com">CardPak</a>, the pioneer in developing and manufacturing environmentally sustainable packaging, announced the promotion of Seth Duckworth to Vice President Sales & Marketing.  Mr. Duckworth joined CardPak in April of 2011 as Central Region Sales Manager.  In June of 2011, Mr. Duckworth was promoted to National Sales Manager.  "Our business is booming and Seth has played a major role in the growth.  His 'can do' attitude and collaborative approach have contributed to significant business from both new and existing clients," said Greg Tisone, CardPak President.  "We are thrilled to have Seth's talent and experience on our management team," continued Tisone. </p>

<p>"I'm thrilled to be part of the CardPak team.  We don't subscribe to the typical client-vendor relationship like most packaging companies.  Rather, we are true partners with our clients.  We strive to consistently meet their needs, by being flexible, reliable and cost competitive.  Our operation is agile, so we can deliver quickly, and help our customers win.  It's what makes CardPak different and better, and why our business is exploding," said Seth Duckworth.</p>

<p>Prior to joining CardPak, Mr. Duckworth served as Tegrant/Alloyd's Director of the Midwest.  Mr. Duckworth earned a bachelor's degree in economics management from Ohio Wesleyan University.<br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/cardpak_announces_promotion_of.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/cardpak_announces_promotion_of.php</guid>
         <category>Community News</category>
         <pubDate>Mon, 14 May 2012 13:37:05 +0000</pubDate>
      </item>
      
      <item>
         <title>Digital printing for coding and serialization</title>
         <description><![CDATA[<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><a href="http://www.healthcarepackaging.com/archives/assets_c/2012/05/Atlantic Zeiser_DELTA105_18037_2-6114.php" onclick="window.open('http://www.healthcarepackaging.com/archives/assets_c/2012/05/Atlantic Zeiser_DELTA105_18037_2-6114.php','popup','width=534,height=620,scrollbars=no,resizable=no,toolbar=no,directories=no,location=no,menubar=no,status=no,left=0,top=0'); return false"><img src="http://www.healthcarepackaging.com/archives/assets_c/2012/05/Atlantic Zeiser_DELTA105_18037_2-thumb-225x261-6114.jpg" width="225" height="261" alt="Atlantic Zeiser_DELTA105_18037_2.jpg" class="mt-image-none" style="" /></a></span><br />
<a href="http://www.atlanticzeiser.com">Atlantic Zeiser's</a> printing module DELTA™ 105i forms the centrepiece of secure coding and serializing in printing bank notes, excise labels, and security documents. Offers an ink-jet component for the high-speed printing of variable data. For coding sheets and flat packaging, the DELTA 105i digital printer and the VERICAM verification system can be optionally integrated. This combination ensures maximum print quality and speeds between 7,500 and 14,000 sheets/hr. Uses either UV or water-based inks for printing. <br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/digital_printing_for_coding_an.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/digital_printing_for_coding_an.php</guid>
         <category>Coding,  marking,  printing</category>
         <pubDate>Mon, 14 May 2012 13:31:17 +0000</pubDate>
      </item>
      
      <item>
         <title>UPS delivers $9 million of flu vaccine to Laos</title>
         <description><![CDATA[<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><a href="http://www.healthcarepackaging.com/archives/assets_c/2012/05/UPS IMG_5228-6110.php" onclick="window.open('http://www.healthcarepackaging.com/archives/assets_c/2012/05/UPS IMG_5228-6110.php','popup','width=618,height=412,scrollbars=no,resizable=no,toolbar=no,directories=no,location=no,menubar=no,status=no,left=0,top=0'); return false"><img src="http://www.healthcarepackaging.com/archives/assets_c/2012/05/UPS IMG_5228-thumb-225x150-6110.jpg" width="225" height="150" alt="UPS IMG_5228.jpg" class="mt-image-none" style="" /></a></span></p>

<p><em>Walgreens donates 375,000 doses that UPS air-ships more than 9,000 miles in five days through five countries, maintaining mandatory 2° to 8°C temperatures through a range of climates.</em><br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/ups_delivers_9_million_of_flu.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/ups_delivers_9_million_of_flu.php</guid>
         <category>Distribution,  package testing,  cold chain</category>
         <pubDate>Fri, 11 May 2012 13:43:56 +0000</pubDate>
      </item>
      
      <item>
         <title>BERICAP Singapore Marks First Anniversary of Production Site</title>
         <description><![CDATA[<p>At the end of 2010 <a href="http://www.bericap.com">BERICAP</a> opened a new production site in Singapore with the goal of successfully advancing business in a central location in Southeast Asia and to improve customer service which up until that time was handled from China or other BERICAP locations. </p>

<p>During the first year in particular, an experienced team of BERICAP employees from China and Germany was on location in a supportive role to ensure BERICAP&#8217;s high quality and efficiency.</p>

<p>In Singapore closures are mainly manufactured for the chemical/ technical and edible oil sectors for export customers in Australia and mainly in Asia. This year the production of beverage closures for Thai customers is slated to be expanded.</p>

<p>The location which meanwhile numbers 35 employees has a large enough area to expand the previous product program and thus in 2012 to double the production of the first fiscal year.<br />
</p>]]></description>
         <link>http://www.healthcarepackaging.com/archives/2012/05/bericap_singapore_marks_first.php</link>
         <guid>http://www.healthcarepackaging.com/archives/2012/05/bericap_singapore_marks_first.php</guid>
         <category>Community News</category>
         <pubDate>Fri, 11 May 2012 13:20:47 +0000</pubDate>
      </item>
      
   </channel>
</rss>

